Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
24m
Lilly’s Kisunla does not demonstrate “good value” for UK’s NHS
The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.
pharmaphorum
20m
UK launches scheme to boost dementia trial participation
The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...
21m
on MSN
New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months. View on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Workers reject new contract
Settles civil lawsuit
NK troops in RU confirmed
Joins Republican Party
Suffers 'debilitating' stroke
Court orders new sentence
'Tarzan' star Ron Ely dies
Closing argument speech plan
Yelp disables reviews
$3.9B storm relief proposal
FDA recalls antidepressant
Israel strikes Lebanese city
Dodgers legend dies
MO court upholds release
DOJ alleges racial bias
Biden says lock up Trump
DNC office shootings arrest
Hashem Safieddine killed
US fines American Airlines
Bird flu infects 4 in WA
G7 Ukraine loan advances
Apple, Goldman Sachs fined
Timberlake postpones shows
Kentucky lawmaker dies
First father-son duo in NBA
Existing home sales fall
Settles hazardous waste suit
Lake Erie toxic algae study
To close 150 locations
Related topics
Alzheimer
Eli Lilly and Company
United Kingdom
National Health Service
NHS
Feedback